Summit Therapeutics Inc. - COM (SMMT)

Historical Holders from Q3 2020 to Q3 2025

Symbol
SMMT on Nasdaq
CUSIP
86627T108
Type / Class
Equity / COM
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
97.8M
Holdings value
$2.08B
% of all portfolios
0.005%
Grand Portfolio weight change
+0%
Number of holders
225
Number of buys
129
Number of sells
-111
Average Value change %
+0%
Average buys %
+0.004%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Summit Therapeutics Inc. - COM (SMMT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1M $20.7M +$12.1M $20.66 17
2025 Q2 97.8M $2.08B +$34.1M $21.28 225
2025 Q1 97.7M $1.89B +$89M $19.29 199
2024 Q4 92.6M $1.65B +$118M $17.85 193
2024 Q3 84.4M $1.85B +$298M $21.90 166
2024 Q2 72.2M $563M +$188M $7.80 122
2024 Q1 49.1M $203M +$69.8M $4.14 100
2023 Q4 60.9K $159K +$4.51K $2.61 2
2023 Q3 32.3M $60.4M -$5.25M $1.87 90
2023 Q2 34.9M $87.6M +$36.5M $2.51 96
2023 Q1 21.1M $37M +$22.2M $1.75 86
2022 Q4 8M $34M +$22.2M $4.25 56
2022 Q3 3.17M $3.77M -$5.15M $1.19 37
2022 Q2 8.45M $8.45M -$4.22M $1.00 32
2022 Q1 10.6M $26M -$224K $2.45 42
2021 Q4 10.7M $28.7M -$162K $2.69 47
2021 Q3 10.7M $53.8M -$1.09M $5.01 50
2021 Q2 11M $82.4M +$14.1M $7.46 53
2021 Q1 9.28M $54.5M +$1.36M $5.87 36
2020 Q4 8.51M $40M -$70.1K $4.70 28
2020 Q3 7.75M $26.7M +$26.7M $3.44 14